[ad_1] The agreed upon counterparty terms include $ 15 million of Orgenesis shares valued at $ 7 to be issued to accredited Koligo investors. Inc () announced on Tuesday the acquisition of Koligo Therapeutics Inc, a regenerative medicine company, before the end of the year. According to a statement, Koligo …

[ad_1] Aziyo Biologics, which makes regenerative medical products for various types of tissues, filed with the SEC on Monday to raise $ 58 million in an initial public offering. Through its proprietary tissue processing platforms, the company has developed a portfolio of advanced regenerative medical products designed to be similar …